Letter to the Editor Regarding Article "Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset"
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Concerns are raised regarding a convolutional neural network's breast MRI analysis for chemotherapy response. Potential data leakage may inflate performance metrics, suggesting the model memorized patient data rather than learning predictive features.
Area Of Science
- Medical Imaging Analysis
- Artificial Intelligence in Oncology
- Machine Learning for Treatment Response Prediction
Background
- A recent study utilized a convolutional neural network (CNN) to predict neoadjuvant chemotherapy response using pre-treatment breast MRI scans.
- The original research reported high performance, with a mean Area Under the ROC curve of 0.98 and 88% accuracy on their test dataset.
Discussion
- This letter questions the validity of the reported results due to potential inadvertent data leakage between training and testing datasets.
- The data split may have occurred at the 2D MRI slice level instead of the patient level, enabling the CNN to memorize individual patient data.
- This memorization, rather than genuine feature discovery, could explain the algorithm's seemingly high performance in predicting treatment outcomes.
Key Insights
- The primary concern is that the CNN's impressive performance might be an artifact of data leakage, not true predictive capability.
- Patient-level data splitting is crucial for robust machine learning model development in medical imaging to prevent outcome memorization.
- Experiments on a public dataset demonstrated that slice-level data leakage can indeed replicate the high performance metrics reported in the original study.
Outlook
- Further validation using rigorously curated, patient-level split datasets is essential for reliable AI-driven treatment response prediction in breast cancer.
- Development of standardized data splitting protocols for medical imaging AI is recommended to ensure model generalizability and trustworthiness.
- Future research should focus on developing AI models that generalize across patients by learning true biological or imaging biomarkers of treatment response.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.